Thieno[2,3-c]pyrrol-4-one derivatives as erk inhibitors

The present invention provides thieno[2,3-c]pyrrol-4-one compounds that inhibit activity of extracellular-signal-regulated kinase (ERK) and may be useful in the treatment of cancer.

Saved in:
Bibliographic Details
Main Authors Zhao, Gaiying, Joseph, Sajan, Mcmillen, William T, Rodriguez, Michael John, Mclean, Johnathan Alexander, Cortez, Guillermo S
Format Patent
LanguageEnglish
Published 21.12.2018
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention provides thieno[2,3-c]pyrrol-4-one compounds that inhibit activity of extracellular-signal-regulated kinase (ERK) and may be useful in the treatment of cancer.
Bibliography:Application Number: NZ20150731531